Dendreon's IPO

Dendreon raised a round of funding on June 16, 2000. Investors include Public.

Dendreon is a biopharmaceutical company targeting cancer through the discovery, development, commercialization, and manufacturing of novel therapeutics. Its product Provenge is an autologous cellular …

Articles about Dendreon's IPO: